As health sciences researchers conduct clinical trials to develop safe and effective therapies and vaccines for COVID-19, two nontrial pre-approval access pathways — expanded access and right-to-try — are becoming more widely-known to the general public.
Other News
We are delighted to extend a heartfelt welcome to President Rebecca Cunningham.
Communities of practice brings together individuals with shared interests or passions.
Through Project REACH, Ben Cahill worked on increasing housing opportunities for individuals facing chronic health conditions in…